Hemagglutinating and complement-fixing antigens of La Crosse virus (California arbovirus group) were produced in serum-free suspension cultures of BHK-21/13S cells. The appearance and production of these antigens were correlated with the titer of infectious virus. No significant differences in antigen titers were produced by varying virus dose 10-fold. Hemagglutinin appeared 6 to 8 hr after inoculation and reached peak titer in 14 to 22 hr. Both,-propiolactone complement-fixing (CF) antigen, they have given inconsistent results in producing satisfactory hemagglutinating (HA) antigens.
cases of encephalitis to a new virus which they called California encephalitis virus. After these cases were described, several diagnostic laboratories used this virus as antigen in serological screening of suspect cases for the diagnosis of arboviral encephalitis. Since additional cases were not confirmed, the laboratories gradually dropped this virus from their battery of tests (7) . No other cases were observed until 1963, when Quick et al. reported a single case of clinical encephalitis in Florida caused by a California group virus (12) . Then in 1964 Thompson et al. reported the isolation of a new antigenic member of the group, La Crosse virus, from the brain of a child who had died of encephalitis in La Crosse, Wisc., in 1960 (15 (3) .
Although standard procedures of Clarke and Casals (2) have been used to produce La Crosse I On leave of absence from the Department of Virology, University of Turku, Turku, Finland. complement-fixing (CF) antigen, they have given inconsistent results in producing satisfactory hemagglutinating (HA) antigens.
Since the BHK-21 continuous line of baby hamster kidney cells had been successfully used to produce antigens for other arboviruses (4) and since Murphy et al. had reported growing La Crosse virus in it (11), this cell line was investigated for the production of La Crosse virus diagnostic antigens. The successful production of infectious La Crosse virus and inactivated CF and HA antigens in serum-free suspension cultures of BHK-21 cells is described in the present report, along with data on the serological sensitivity and storage stability of the antigens.
MATERILUS AND METHODS Cell cultures. A culture of BHK-21/13S was maintained by the methods reported previously (5, 6) with minor modifications. Monolayers were grown in 32-oz (947 ml) prescription bottles (Brockway Glass Co., Brockway, Pa.) containing 50 ml of BHK-21 growth medium which contained 10% heat-inactivated, fetal calf serum, and 10% tryptose phosphate broth. Cul-tures were trypsinized and divided into six subcultures twice weekly. To produce cells for suspension cultures, eight 32-oz monolayer cultures were grown at 35 C for 3 to 4 days. These monolayers were trypsinized, and the cells (about 8 X 108) were suspended in 800 ml of growth medium. The suspension cultures were grown for 24 hr in sealed, 1-liter Pyrex bottles at 35 C and then inoculated with virus.
Preparation of antigen. To produce antigen, 24-hr suspension cultures were centrifuged at 4 C for 10 min at 200 X g. The supernatant medium was discarded, and the packed cells were resuspended to give about 1.2 X 109 cells in 100 ml of bovalbumin (BA) medium. The BA medium was the same as growth medium except that the fetal calf serum was replaced by 0.4% bovine plasma albumin, fraction V (Armour Pharmaceutical Co., Chicago, Ill.). The cells were then inoculated with the desired dose of seed virus and incubated at 35 C for 2 hr, with gentle agitation every 20 min. Enough BA medium was added to bring each culture up to 800 ml, and the pH was adjusted to between 7.0 and 7.2 with 5% NaHCO3 solution. The infected suspension cultures were incubated at 35 C on a magnetic stirrer. To maintain an alkaline pH, the screw cap was not tightened. In some instances, a medium change was made after about 24 hr of incubation. This was accomplished by centrifugation, as described above, and by resuspension of cells in 800 ml of fresh BA medium.
Inactivation of infectious antigens. Two methods were tested for their ability to inactivate residual infectious virus in the final antigens. In one method, tissue culture derived antigens were extracted with Tween 80 and ether, as described elsewhere (6) . In the second method, antigens were treated with the following final concentrations of fi propiolactone (BPL): 0.01, 0.025, 0.05, 0.1, and 0.2% (14) .
Storage stability. To determine the most suitable conditions for storing Tween 80-ether-extracted antigen, the antigen preparation was divided into two equal volumes and treated as follows: one-half was lyophilized and the other half was dispensed in screw-cap vials in the liquid state. Ampoules of dried antigen were stored at 24, 5, -20, and -60 C. Samples of each were tested for HA activity at 0, 7, 13, 27, 61, 117, and 365 days.
Virus and antigen assays. Viable virus was assayed in BHK-21/C-13 cells by plaquing in 3-oz (89 ml) prescription bottles (Chappell, Coleman, and Elliott, in preparation). In this procedure two overlays were used. The first overlay medium, which was applied 1 hr after inoculation, consisted of 1% agarose prepared in Earle's balanced salt solution with a final concentration of 330 ,ug of yeast extract and 1,650 1Ag of lactalbumin hydrolysate per ml. The second overlay medium, which was added 2 days after inoculation, was the same as the first overlay except that it contained neutral red and that agarose was replaced by Noble agar.
Hemagglutination and hemagglutination-inhibition tests were carried out in plastic microtiter plates (8) by the method of Clarke and Casals (2) . Optimal hemagglutination by La Crosse antigen occurred at pH 6.0 at 37 C. Four hemagglutinating units of each antigen were used, and serum-antigen mixtures were held at 5 C overnight before the addition of goose erythrocytes. The immune ascitic fluids used were prepared in mice after vaccinations with La Crosse, Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and St. Louis encephalitis (SLE), according to the method of Tikasingh et al. (17) . All sera were adsorbed with kaolin and goose erythrocytes.
CF tests were performed by the microtiter Laboratory Branch Complement Fixation method by using five 50% units of complement (1) . Undiluted cell culture supernatant fluid was used as the CF antigen.
Comparison of mouse brain and cell culture HA antigens. HA antigen derived from infected mouse brains was compared with that prepared in BHK-21 suspension cultures. The brain antigen was prepared by the sucrose-acetone extraction method of Clarke and Casals (2) . Human sera for the comparative study were selected on the basis of their neutralization antibody content for La Crosse virus. Undiluted sera that caused at least 90% plaque reduction in BHK-21/ C-1 3 cells were considered positivefor neutralizing antibody. All sera were adsorbed with kaolin and goose erythrocytes before use in hemagglutination-inhibition (HI) tests.
RESULTS

Results of initial studies showed that La
Crosse HA antigen could be successfully produced in BHK-21/1 3S suspension cultures. Hemagglutinin was first detected 8 hr after inoculation, and peak titers of 1:64 to 1:128 were reached within 22 to 24 hr. Additional studies were performed to determine (i) the effects of changing the medium and the dose of virus inoculum on HA production, (ii) suitable methods of inactivating the infectious antigen, and (iii) optimal storage conditions for the antigen.
Effect of medium change. Table 2 . Table 2 reveals a 10-fold differproduction. Two ence in infective virus titers between the two cul-/13S were pre-tures at 2 hr. By the 22nd hr both cultures had jual number of about the same titer. At 22 hr the cultures were ilated with 0.1 centrifuged, and fresh BA medium was added. and culture no. The titer then declined in both cultures; the Is per cell. Both decline was more rapid, however, in culture ally and were no. 2, which had received the higher virus dose.
Samples were
In both cultures, HA and CF antigens were tested for HA present by the 22nd hr. A significant reduction nfectivity. The of HA followed the medium change, but the CF diately after the titer was unaltered. Within about 24 hr after the and additional medium change, hemagglutinin activity had reappeared, but the titer remained lower than at ye of La Crosse 22 hr. (6) , rabies, vesicular stomatitis, Cocal, Kern Canyon, and Flanders viruses (4). We have found that this method for the production of La Crosse virus hemagglutinin yields a better quality and is more reproducible than the procedure in which mouse brain is used as an antigen source. In our laboratories, we have successfully produced 16 consecutive batches of antigen with this procedure. Furthermore, hemagglutinin can be produced within 22 to 24 hr after virus is added to cell cultures. Although the highest HA titer of antigen obtained was 1:128, the volume produced in each lot was 800 ml. By treating this product with Tween 80 and ether, all apparent virus infectivity is destroyed without essentially decreasing HA activity. The product is then safe for use in any laboratory as a CF or HA antigen.
One of the most important properties of a HA antigen is its sensitivity in detecting homologous antibody. In the tests to compare cell culture-produced antigen with brain-derived antigen in detection of HI antibody in human sera, the cell culture antigen was more sensitive. Titers obtained were as much as eightfold greater than those obtained with the brain antigen. Furthermore, with the brain-derived antigen, about 20% fewer sera were positive.
The antigenic patterns among the members of the California group of viruses have been studied by complement fixation, neutralization (13) , and immunodiffusion (10); however, complete analysis of the group has not been possible because of lack of hemagglutinins. It is hoped that the method of antigen production reported in this study for La Crosse virus will lead to the production of HA antigens for other members of the California group so that more complete studies of antigenic relationships of these viruses can be conducted.
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